Vista Pharmaceuticals Limited (BOM:524711)
India flag India · Delayed Price · Currency is INR
8.01
-0.31 (-3.73%)
At close: Jan 22, 2026

Vista Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jan '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
487825706312339404
Upgrade
Market Cap Growth
-47.04%16.93%126.29%-8.06%-15.96%150.81%
Upgrade
Enterprise Value
571867796445499517
Upgrade
Last Close Price
7.9210.7410.668.369.229.04
Upgrade
PS Ratio
5.568.196.8631.0885.9931.87
Upgrade
PB Ratio
1.091.821.740.850.961.23
Upgrade
P/TBV Ratio
1.392.302.281.151.311.23
Upgrade
EV/Sales Ratio
6.528.617.7444.35126.4040.78
Upgrade
EV/FCF Ratio
-8.88-----
Upgrade
Debt / Equity Ratio
0.190.160.200.270.350.33
Upgrade
Asset Turnover
0.140.170.180.020.010.03
Upgrade
Inventory Turnover
0.961.141.280.340.040.09
Upgrade
Quick Ratio
0.310.420.360.900.910.35
Upgrade
Current Ratio
1.131.190.921.691.861.65
Upgrade
Return on Equity (ROE)
-14.42%-10.82%-11.69%-15.69%-2.60%-6.43%
Upgrade
Return on Assets (ROA)
-7.61%-4.90%-4.28%-5.04%-2.15%-3.01%
Upgrade
Return on Invested Capital (ROIC)
-14.44%-9.22%-8.24%-9.54%-4.00%-5.57%
Upgrade
Return on Capital Employed (ROCE)
-16.10%-9.70%-9.00%-10.70%-4.30%-5.90%
Upgrade
Earnings Yield
-13.74%-5.63%-6.39%-18.15%-2.62%-4.98%
Upgrade
FCF Yield
-13.19%-9.00%-8.08%-9.56%-2.97%-17.46%
Upgrade
Buyback Yield / Dilution
-11.64%-34.66%-18.55%-0.11%-6.18%-14.11%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.